The mysterious case of Eli Lilly’s obesity drug

Дата публикации: 25-06-2026 18:58:44

Who got exclusive access to Eli Lilly's highly anticipated obesity candidate? And why are drugmakers spending so much on acquisitions? Find out on this week's "Readout LOUD."

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	STAT+: Democrats press White House on who got special access to Eli Lilly’s new obesity drug	0	7	25-06-2026
2	STAT+: Embryo editing advances reignite ethical debates	0	5	26-06-2026
3	Supreme Court rules in weedkiller cancer case	0	5	26-06-2026
4	What is pulmonary hypertension and why would a new GLP-1 help?	0	5	26-06-2026
5	Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity	7	8	31-07-2025
6	Taxation With Representation: Sidley, Paul Weiss, Kirkland	0	5	26-06-2026
7	STAT+: Pharmalittle: We’re reading about a bill to overhaul the 340B program, a new FDA commissioner candidate, and more	0	3	26-06-2026
8	Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days	0	5	31-07-2025
9	3 Firms Steer Cargo Drone Co.'s $800M SPAC Merger	0	5	26-06-2026
10	STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better	0	7	25-06-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: www.statnews.com.